中文
Home  >  News & Media  >  Industry News

CFDA issues reform plan for chemical drug registration classification

 

In order to encourage drug innovation, standardize evaluation and approval, improve drug quality, promote industrial upgrading and reform current chemical drug registration classification, China Food and Drug Administration (CFDA) formulated the reform plan for chemical drug registration classification. CFDA issued an announcement on March 4, 2016, which released the reform plan for chemical drug registration classification. The reform plan came into force from the date of promulgation.